Related Experiment Video
Updated: Aug 15, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis
Reza Naeimi1, Mahdi Sepidarkish2, Abolfazl Mollalo3
1Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Insights
SARS-CoV-2 seroprevalence in children increased significantly during the pandemic, with 50-70% remaining susceptible by late 2021. This highlights the urgent need for improved pediatric vaccination strategies, especially in developing nations and minority groups.
Area of Science:
- * Epidemiology
- * Infectious Diseases
- * Pediatrics
Background:
- * Rising hospitalization rates in children (0-19 years) due to SARS-CoV-2 Omicron variant.
- * Persistent disparities in pediatric COVID-19 vaccination coverage.
- * Need for comprehensive understanding of SARS-CoV-2 sero-epidemiology in pediatric populations.
Purpose of the Study:
- * To systematically review and assess global SARS-CoV-2 seroprevalence in children.
- * To identify determinants associated with SARS-CoV-2 seropositivity in pediatric populations worldwide.
Main Methods:
- * Systematic review and meta-analysis of international scientific databases and preprints (December 2019 - July 2022).
- * Pooled seroprevalence estimation by WHO regions using random-effects meta-analyses.
- * Sub-group and meta-regression analyses to investigate heterogeneity and associations.
Main Results:
- * 247 studies included, encompassing 757,075 children from 70 countries.
- * Seroprevalence increased from 7.3% in wave 1 to 56.6% in wave 6.
- * Highest seroprevalence in South-East Asia and Africa; lowest in Western Pacific. Higher rates observed in older children, underprivileged regions, and minority ethnic groups.
Conclusions:
- * Significant proportion of children remained susceptible to SARS-CoV-2 by late 2021, pre-Omicron wave.
- * Urgent need for enhanced vaccine efficacy and improved vaccination coverage in children and adolescents.
- * Particular focus required on developing countries and minority ethnic groups to address vaccination disparities.
Background:
The higher hospitalisation rates of those aged 0-19 years (referred to herein as 'children') observed since the emergence of the immune-evasive SARS-CoV-2 Omicron variant and subvariants, along with the persisting vaccination disparities highlighted a need for in-depth knowledge of SARS-CoV-2 sero-epidemiology in children. Here, we conducted this systematic review to assess SARS-CoV-2 seroprevalence and determinants in children worldwide.
Methods:
In this systematic review and meta-analysis study, we searched international and preprinted scientific databases from December 1, 2019 to July 10, 2022. Pooled seroprevalences were estimated according to World Health Organization (WHO) regions (at 95% confidence intervals, CIs) using random-effects meta-analyses. Associations with SARS-CoV-2 seroprevalence and sources of heterogeneity were investigated using sub-group and meta-regression analyses. The protocol used in this study has been registered in PROSPERO (CRD42022350833).
Findings:
We included 247 studies involving 757,075 children from 70 countries. Seroprevalence estimates varied from 7.3% (5.8-9.1%) in the first wave of the COVID-19 pandemic to 37.6% (18.1-59.4%) in the fifth wave and 56.6% (52.8-60.5%) in the sixth wave. The highest seroprevalences in different pandemic waves were estimated for South-East Asia (17.9-81.8%) and African (17.2-66.1%) regions; while the lowest seroprevalence was estimated for the Western Pacific region (0.01-1.01%). Seroprevalence estimates were higher in children at older ages, in those living in underprivileged countries or regions, and in those of minority ethnic backgrounds.
Interpretation:
Our findings indicate that, by the end of 2021 and before the Omicron wave, around 50-70% of children globally were still susceptible to SARS-CoV-2 infection, clearly emphasising the need for more effective vaccines and better vaccination coverage among children and adolescents, particularly in developing countries and minority ethnic groups.
Funding:
None.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Single Nucleotide Polymorphisms-SNPs
Bias in Epidemiological Studies
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Statistical Methods for Analyzing Epidemiological Data

